Skip to main content
. 2021 Jun 24;36(4):473–481. doi: 10.46497/ArchRheumatol.2021.8364

Table 5. Analysis of factors affecting complaints after treatment changes.

  Increased Decreased Unchanged p
n % n % n %
Continued medications-1*             <0.001
Yes 16 9.0 1 0.6 161 90.4  
No 75 75.8 2 2.0 22 22.2  
Continued medications-2*             <0.001a
Continued as it was before 16 9.0 1 0.6 161 90.4 <0.001b
Stopped all of the medications 31 79.5 2 5.1 6 15.4 <0.001c
Stopped only biological and synthetic therapy 18 81.8 0 0 4 18.2 1.000d
Decreased or skipped the dose of biological therapy 26 68.4 0 0 12 31.6 1.000e
0.993f
Receiving infusion therapy*             0.024
Yes 26 48.1 0 0 28 51.9  
No 65 29.3 3 1.4 154 69.4  
* p<0.001, Chi square test, p-values were adjusted using Bonferroni method for pairwise comparisons. pa: Continued as it was before vs. decreased or skipped the dose of biological therapy pb: Continued as it was before vs. stopped only biological and synthetic therapy pc: Continued as it was before vs. stopped all of the medications pd: Stopped only biological and synthetic therapy vs.decreased or skipped the dose of biological therapy pe: Stopped only biological and synthetic therapy vs. stopped all of the medications pf: Stopped all of the medications vs. decreased or skipped the dose of biological therapy